Table 2. Prevalence of Fabry disease by Japanese region, based on the number of beneficiaries identified from clinical research data as part of the Specified Disease Treatment Research Program and Japanese population data (2005 census).
Males | Females | Total | |||||||
Region of Japan | Number | Prevalencea | Standardized prevalence ratio |
Number | Prevalencea | Standardized prevalence ratio |
Number | Prevalencea | Standardized prevalence ratio |
Hokkaido | 1 | 0.04 | 0.12b | 1 | 0.03 | 0.18b | 2 | 0.04 | 0.15b |
Tohoku | 23 | 0.50 | 1.64b | 13 | 0.26 | 1.45 | 36 | 0.37 | 1.57b |
Kanto | 69 | 0.33 | 1.00 | 43 | 0.21 | 1.15 | 112 | 0.27 | 1.06 |
Koshinetsu/ Hokuriku | 20 | 0.48 | 1.58 | 10 | 0.23 | 1.28 | 30 | 0.35 | 1.47 |
Tokai | 27 | 0.36 | 1.14 | 20 | 0.26 | 1.49 | 47 | 0.31 | 1.27 |
Kinki | 21 | 0.21 | 0.66b | 9 | 0.08 | 0.47b | 30 | 0.14 | 0.59b |
Chugoku | 9 | 0.24 | 0.81 | 3 | 0.08 | 0.43b | 12 | 0.16 | 0.66 |
Shikoku | 6 | 0.31 | 1.03 | 6 | 0.28 | 1.56 | 12 | 0.29 | 1.24 |
Kyushu | 22 | 0.32 | 1.02 | 12 | 0.15 | 0.87 | 34 | 0.23 | 0.95 |
Total | 198 | 0.32 | 117 | 0.18 | 315 | 0.25 |
aPer 100 000 individuals in 2005.
bSignificantly higher or lower (P < 0.05).